Literature DB >> 27556236

Asymptomatic Atherosclerosis in Primary Sjögren Syndrome: Correlation Between Low Ankle Brachial Index and Autoantibodies Positivity.

Ana Beatriz Andrêo Garcia1, Luciana Paula Dardin, Paulo Alexandre Minali, Adriano Czapkowsky, Sergio Aron Ajzen, Virginia Fernandes Moça Trevisani.   

Abstract

BACKGROUND: Primary Sjögren syndrome is a chronic inflammatory autoimmune disease. The delay in diagnosis allows the establishment of a chronic inflammatory state, which makes primary Sjögren syndrome an interesting model for the study of atherosclerosis.
OBJECTIVES: The aim of this study was to evaluate subclinical atherosclerosis in 49 patients with Sjögren syndrome using noninvasive methods.
METHODS: We assessed traditional risk factors such as hypertension, diabetes, dyslipidemia, smoking, and family history of atherosclerosis. Patients with prior cardiovascular events and a history of atherosclerosis were excluded. Clinical and laboratory features were recorded, as well as the European League Against Rheumatism Sjögren's Syndrome Activity Index calculation. The atherosclerosis evaluation was done by carotid intima-media thickness, measured by ultrasonography, and ankle-brachial index (ABI).
RESULTS: Fifteen patients (31%) had at least 1 traditional risk factor, and 65.3% had a European League Against Rheumatism Sjögren's Syndrome Activity Index score from mild to moderate. Only 2 patients had increased carotid intima-media thickness. However, 59% presented ABI alterations. Multiple correspondence analysis showed a clear correlation between low ABI and the positivity of autoantibodies (antinuclear antibodies, anti-SSA, rheumatoid factor).
CONCLUSIONS: The subgroup of patients with positive autoantibodies showed low ABI, which may represent a higher risk of early atherosclerosis and indicate the need for more careful monitoring in this group.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27556236     DOI: 10.1097/RHU.0000000000000413

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  8 in total

Review 1.  Cardiovascular Involvement in Sjögren's Syndrome.

Authors:  Fabiola Atzeni; Francesco Gozza; Giacomo Cafaro; Carlo Perricone; Elena Bartoloni
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.

Authors:  Cem Ozisler; Hatice Kaplanoglu
Journal:  Clin Rheumatol       Date:  2018-10-17       Impact factor: 2.980

3.  Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Authors:  J Mofors; M Holmqvist; L Westermark; A Björk; M Kvarnström; H Forsblad-d'Elia; S Magnusson Bucher; P Eriksson; E Theander; T Mandl; M Wahren-Herlenius; G Nordmark
Journal:  J Intern Med       Date:  2019-06-17       Impact factor: 8.989

4.  Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in primary Sjögren syndrome.

Authors:  Selcan Gültuna; Sevinç Can Sandıkçı; Hatice Kaplanoğlu; Fevzi Nuri Aydın; Funda Seher Özalp Ateş
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.007

5.  Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.

Authors:  Xue-Fen Wu; Jing-Yang Huang; Jeng-Yuan Chiou; Huang-Hsi Chen; James Cheng-Chung Wei; Ling-Li Dong
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

6.  Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases.

Authors:  Javier Rodríguez-Carrio; Lourdes Mozo; Patricia López; Elena Nikiphorou; Ana Suárez
Journal:  Front Med (Lausanne)       Date:  2018-04-23

7.  Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan.

Authors:  Yi-Da Tsai; Wu-Chien Chien; Shih-Hung Tsai; Chi-Hsiang Chung; Shi-Jye Chu; Sy-Jou Chen; Wen-I Liao; Chih-Jen Yang; Min-Tser Liao; Jen-Chun Wang
Journal:  BMJ Open       Date:  2018-09-21       Impact factor: 2.692

8.  Association of antinuclear antibodies with the risk of intracranial arterial stenosis.

Authors:  Yong-An Sun; Qiu Han; Xiao-He Hou; Xian-Zhen Peng; Lin Tong; Xu Zheng; Jin-Tai Yu; Lan Tan
Journal:  Aging (Albany NY)       Date:  2020-01-21       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.